Zovia Related Published Studies
Well-designed clinical trials related to Zovia (Ethynodiol / Estradiol)
Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. [1979.02]
Well-designed clinical trials possibly related to Zovia (Ethynodiol / Estradiol)
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. [1995.12]
Oral contraceptive administration, interfemale relationships, and sexual behavior in Macaca fascicularis. [1990.04]
Programmed ovulation induction and oocyte retrieval for in vitro fertilization. [1988.06]
Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial. [1988.01]
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study. [1986.08]
Other research related to Zovia (Ethynodiol / Estradiol)
Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial. [1991.04]
Complexion changes in oral contraceptive users. Results from a phase IV multicenter trial evaluating the safety and efficacy of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms. [1991.04]
Serum and placenta levels of ethynylestradiol in presence of ethynodiol diacetate after oral administration. [1982.07]
Other possibly related research studies
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. [1998.08]
A changing pattern in the association of oral contraceptives and the different groups of congenital limb deficiencies. [1995.01]
Effects of desogestrel on carbohydrate metabolism. [1993.03]
Menometrorrhagia in an oral contraceptive user. [1993.02]
Incidence of breakthrough bleeding during oral contraceptive therapy. [1991.04]
Oral contraception: a review. [1991]
Modern trends in contraception. [1990.12]
Oral contraceptives and cardiovascular risk. Taking a safe course of action. [1990.09.15]
Use of spironolactone in treatment of hirsutism. [1990.05]
Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. [1990.02]
Choosing the best oral contraceptive. [1989.06]
Attempts with lipanthyl to improve lipid metabolism during the adaptation period of women taking oral contraceptives. [1989]
The varying effects of progestins on lipid levels and cardiovascular disease. [1988.06]
Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins. [1988.01]
Action of hormonal contraceptives on the coagulation system and some of its inhibitors. [1986]
Iron stores in users of oral contraceptive agents. [1985.04]
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. [1984.12]
Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents. [1983.11]
Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. [1982.03.15]
Maternal hormone therapy and congenital heart disease. [1980.04]
Chorea induced by oral contraceptives. [1979.12]
An open assessment of a new low dose oestrogen combined oral contraceptive. [1978]
Progestational potency of oral contraceptives: a polemic. [1978]
[Oral contraceptives in prophylaxis of acute exacerbations of intermittent porphyria (author's transl)] [1976.12.24]
Benign breast tumor and estrogenic hormones: a population-based retrospective study. [1976.05]
Hormonal dependency in Darier disease. [1976.02]
A cytogenetic study in women who had used oral contraceptives and in their progeny. [1975.12]
Hormonal steroids: effects on the vascular system. [1975]
Oral contraceptives and the risk of gallbladder disease: a comparative safety study. [2011.05.17]
|